⌘K

Login Start Free

Home/Filings/4/0001127602-25-002790

4//SEC Filing

FOSTER JAMES C 4

Accession 0001127602-25-002790

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:03 PM ET

Size

11.1 KB

Accession

0001127602-25-002790

Insider Transaction Report

Form 4

Period: 2025-01-31

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2025-01-31$165.57/sh−6,827$1,130,346→ 197,564 total
Award
Common Stock
2025-01-31+19,608→ 204,391 total

Holdings

Common Stock
(indirect: 2024 GRAT)
20,000
Common Stock
(indirect: 2022 GRAT)
4,048
Common Stock
(indirect: By Trust)
2,250
Common Stock
(indirect: By Trust)
230
Common Stock
(indirect: By Trust)
750
Common Stock
(indirect: By Spouse)
10,000
Common Stock
(indirect: 2023 GRAT)
9,793

Footnotes (1)

[F1]Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1

filerCIK 0001141722

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 5:03 PM ET
Size: 11.1 KB

View on SEC.gov